Researchers have come up with a new, patient-reported questionnaire to measure the impact of digital ulcers on hand function in…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
A specific variant in the STAT4 gene protects people with scleroderma against the development of interstitial…
Advanced Ultrasound of Skin May Best Determine Scleroderma Activity and Progression, Study Suggests
An advanced imaging technique, called ultra-high-frequency ultrasound (UHF-US), provides detailed information of all skin layers to better detect and…
Black patients with scleroderma experience faster disease progression, higher prevalence of diffuse skin involvement, and higher mortality than…
People with systemic scleroderma (SSc) can be prone to problems in the small…
Older men with diffuse cutaneous systemic scleroderma (dcSSc) have more estradiol, a form of estrogen, compared with postmenopausal…
Certain cytokines of the IL-1 family may play important and distinct roles in the development of systemic scleroderma…
TLY012, a lab-made equivalent of a natural protein called TRAIL, can reverse skin fibrosis in mice with scleroderma by blocking important…
Among patients with systemic sclerosis (SSc), those who have pulmonary…
IGFBP-5, a protein that appears to be involved in the early stages of fibrosis, may be a potential…